Balkan Exedrol 25mg (Exemestane) 100 tabs


Manufacturer: Balkan Pharmaceuticals


  • Manufacturer: Balkan Pharmaceutical
  • Release form: 25mg 100 tab
  • Active ingredient: Exemestane
  • Country: Moldova

Description Balkan EXIDROL

Balkan Exedrol (Exemestane) is a steroidal aromatase inhibitor manufactured by Balkan. Unlike anastrozole and letrozole, which reversibly block aromatase, exemestane completely deactivates this enzyme by binding to its molecules. Aromatase inhibition Balkan Exedrol leads to a significant decrease in the level of estradiol in the blood, which makes the drug effective in the treatment of breast cancer. Due to its effectiveness, exemestane has also found its way into bodybuilding.

Balkan Exedrol, like anastrozole, is an aromatase inhibitor. And even more powerful. Judging by official data, the level of bound aromatase for anastrozole is in the region of 78-80%, while for Balkan Exedrol it is an impressive 85%. At the same time, exemestane is close to anastrozole in terms of cost, so it is rather problematic to say which of the drugs is the best choice in terms of price / quality ratio.

As in the case of Arimidex, the use of only half a Balkan Exedrol tablet gives good results, moreover, the drug can be used not every day, but every two to three days. True, the active substance in the Balkan Exedrol tablet is slightly more than one tablet contains 25 mg of exemestane.

Side effects in Balkan Exedrol when used in the indicated dosage are practically absent.

Dosage Balkan Exedrol

On a course of steroids, it is usually 12.5 mg every other day, 12.5 mg per day, or, very rarely, 25 mg per day. It all depends on the individual reaction of the body.Competitive athletes take 25 mg/day in the last 7-14 days before competition to stiffen the muscles.

On PCT, the dosage of Balkan Exedrol does not exceed 12.5 mg every other day. The interval between doses can reach 3 to 4 days.


There are no reviews yet.

Be the first to review “Balkan Exedrol 25mg (Exemestane) 100 tabs”

Your email address will not be published. Required fields are marked *